AIRLINK 75.25 Decreased By ▼ -0.18 (-0.24%)
BOP 5.11 Increased By ▲ 0.04 (0.79%)
CNERGY 4.60 Decreased By ▼ -0.15 (-3.16%)
DFML 32.53 Increased By ▲ 2.43 (8.07%)
DGKC 90.35 Decreased By ▼ -0.13 (-0.14%)
FCCL 22.98 Increased By ▲ 0.08 (0.35%)
FFBL 33.57 Increased By ▲ 0.62 (1.88%)
FFL 10.04 Decreased By ▼ -0.01 (-0.1%)
GGL 11.05 Decreased By ▼ -0.29 (-2.56%)
HBL 114.90 Increased By ▲ 1.41 (1.24%)
HUBC 137.34 Increased By ▲ 0.83 (0.61%)
HUMNL 9.53 Decreased By ▼ -0.37 (-3.74%)
KEL 4.66 No Change ▼ 0.00 (0%)
KOSM 4.70 Increased By ▲ 0.01 (0.21%)
MLCF 40.54 Decreased By ▼ -0.56 (-1.36%)
OGDC 139.75 Increased By ▲ 4.95 (3.67%)
PAEL 27.65 Increased By ▲ 0.04 (0.14%)
PIAA 24.40 Decreased By ▼ -1.07 (-4.2%)
PIBTL 6.92 No Change ▼ 0.00 (0%)
PPL 125.30 Increased By ▲ 0.85 (0.68%)
PRL 27.55 Increased By ▲ 0.15 (0.55%)
PTC 14.15 Decreased By ▼ -0.35 (-2.41%)
SEARL 61.85 Increased By ▲ 1.65 (2.74%)
SNGP 72.98 Increased By ▲ 2.43 (3.44%)
SSGC 10.59 Increased By ▲ 0.03 (0.28%)
TELE 8.78 Decreased By ▼ -0.11 (-1.24%)
TPLP 11.73 Decreased By ▼ -0.05 (-0.42%)
TRG 66.60 Decreased By ▼ -1.06 (-1.57%)
UNITY 25.15 Decreased By ▼ -0.02 (-0.08%)
WTL 1.44 Decreased By ▼ -0.04 (-2.7%)
BR100 7,803 Increased By 78.1 (1.01%)
BR30 25,816 Increased By 214.9 (0.84%)
KSE100 74,531 Increased By 732.1 (0.99%)
KSE30 23,954 Increased By 330.7 (1.4%)

reckitt LONDON: Consumer goods group Reckitt Benckiser said like-for-like revenue grew 5 percent in the third quarter, underpinned by a strong performance in emerging markets and better trading in North America and Europe.

 

The British maker of Finish dishwasher tablets, Nurofen painkillers and Cillit Bang cleaners, said the results positioned it well to meet its 2012 goals, with market growth now expected to be at the top end of a 1 to 2 percent range.

 

The company is targeting underlying sales growth 200 basis points ahead of the market, i.e a 3 to 4 percent increase, with margins held steady.

 

It said on Wednesday that like-for-like sales, both including and excluding its pharmaceuticals unit, grew by 5 percent in the quarter.

 

That was better than analysts were expecting after the group saw a slowdown in Southern Europe earlier in the year.

 

Analysts at Investec were expecting organic sales growth excluding pharmaceuticals of 3.1 percent, lower than the median analyst consensus of 3.8 percent.

 

Copyright Reuters, 2012

Comments

Comments are closed.